Department of Public Health, Kindai University Faculty of Medicine, 377-2 Oono-higashi, Osaka-Sayama, Osaka 589-8511, Japan.
Department of Public Health, Kindai University Faculty of Medicine, 377-2 Oono-higashi, Osaka-Sayama, Osaka 589-8511, Japan.
Bone. 2021 Jun;147:115912. doi: 10.1016/j.bone.2021.115912. Epub 2021 Mar 16.
Cross-sectional studies have shown that patients with type 2 diabetes mellitus (T2DM) have low circulating levels of osteocalcin (OC) and undercarboxylated OC (ucOC). This longitudinal study aimed to examine whether low OC or ucOC levels at baseline are associated with the risk of incident T2DM.
We examined 1700 community-dwelling Japanese men (≥65 years) after excluding those with history of diseases (other than T2DM) or medications that affect bone and glucose metabolism. T2DM was defined as fasting plasma glucose (FPG) ≥126 mg/dl or glycated hemoglobin A (HbA1c) ≥6.5%. Participants without prevalent T2DM at baseline were invited to follow-up surveys 5 and 10 years after baseline.
Among the participants, 309 with prevalent T2DM showed significantly lower serum OC and ucOC levels at baseline than those without. After excluding these participants, 46 and 57 participants with incident T2DM were identified in the first and second follow-up surveys, respectively. These participants did not show significantly different OC and ucOC levels at baseline relative to those without T2DM, although their FPG and HbA1c levels at baseline were significantly higher compared to those without incident T2DM. Increase in glycemic indices preceded decrease in OC and ucOC levels. OC and ucOC levels at baseline were not significantly associated with the risk of incident T2DM identified in the follow-up surveys.
OC and ucOC levels at baseline were not significantly associated with the risk of incident T2DM. Our results do not support the findings of animal studies that ucOC is a hormone regulating glucose metabolism.
横断面研究表明,2 型糖尿病(T2DM)患者的循环骨钙素(OC)和未羧化 OC(ucOC)水平较低。本纵向研究旨在探讨基线时 OC 或 ucOC 水平较低是否与 T2DM 发病风险相关。
我们检查了 1700 名居住在社区的日本男性(≥65 岁),排除了有其他疾病(除 T2DM 外)或影响骨和葡萄糖代谢的药物史的患者。T2DM 的定义为空腹血糖(FPG)≥126mg/dl 或糖化血红蛋白 A(HbA1c)≥6.5%。基线时无 T2DM 患者受邀参加基线后 5 年和 10 年的随访调查。
在参与者中,309 名患有 T2DM 的患者基线时的血清 OC 和 ucOC 水平显著低于无 T2DM 的患者。排除这些患者后,在第一次和第二次随访调查中分别发现了 46 名和 57 名新发病例 T2DM 患者。与无 T2DM 的患者相比,这些患者的基线 OC 和 ucOC 水平没有显著差异,尽管他们的 FPG 和 HbA1c 水平明显高于无新发病例 T2DM 的患者。血糖指标升高先于 OC 和 ucOC 水平降低。基线时 OC 和 ucOC 水平与随访调查中确定的新发病例 T2DM 的风险无显著相关性。
基线时 OC 和 ucOC 水平与新发病例 T2DM 的风险无显著相关性。我们的结果不支持动物研究发现 ucOC 是调节葡萄糖代谢的激素的观点。